|
US2013079283A1
|
|
Erythropoitein Receptor Peptide Formulations and Uses
|
|
AU2012203812A1
|
|
Erythropoietin receptor peptide formulations and uses
|
|
EP2195002A1
|
|
Erythropoietin receptor peptide formulations and uses
|
|
WO2009002947A2
|
|
Compounds and peptides that bind the trail receptor
|
|
JP2009191056A
|
|
Therapy of disorder mediated by anti-erythropoietin antibody using epo receptor agonist based on synthetic peptide
|
|
EP2118127A2
|
|
Nitrogen-based linkers for attaching modifying groups to polypeptides and other macromolecules
|
|
US2008081783A1
|
|
Erythropoietin receptor peptide formulations and uses
|
|
WO2007070372A2
|
|
Compositions and methods for inhibiting cellular proliferation
|
|
WO2007044153A1
|
|
Derivatization and low level detection of drugs in biological fluid and other solution matrices using a proxy marker
|
|
US2007104704A1
|
|
Erythropoietin receptor peptide formulations and uses
|
|
WO2006062685A2
|
|
Novel peptides that bind to the erythropoietin receptor
|
|
EP1814910A2
|
|
Novel peptides that bind to the erythropoietin receptor
|
|
EP1841446A1
|
|
Peptides and compounds that bind to the il-5 receptor
|
|
TW200614999A
|
|
Novel peptides that bind to the erythropoietin receptor
|
|
MY140065A
|
|
Novel peptides that bind to the erythropoietin receptor
|
|
NZ563042A
|
|
Novel spacer moiety for poly(ethylene glycol)-modified peptide-based compounds
|
|
MXPA05012316A
|
|
Novel peptides that bind to the erythropoietin receptor.
|
|
CN1820024A
|
|
Novel poly(ethylene glycol) modified compounds and uses thereof
|
|
KR20120094001A
|
|
Peptides that bind to the erythropoietin receptor
|
|
AU2002242128A1
|
|
Devices and methods for high throughput patch clamp assays
|
